Redhill Biopharma RDHL Q2 2022 Earnings Massive EPS Miss Raises Liquidity Concerns Disc Medicine Q1 2026 Earnings Narrowed Loss Beats Estimates as Biotech Advances Hematology Pipeline HOLX Q1 2026 Earnings EPS Falls Short of Expectations by 645 CRMD Q1 2026 Earnings Strong EPS Beat Driven by Milestone Payments ECL Q1 2026 Earnings Slight EPS Miss Amid Steady Performance Shares Edge Higher MSC Income Fund Inc MSIF Q1 2026 Earnings EPS Falls Short of Estimates Stock Eases